ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0061178;regulation of insulin secretion involved in cellular response to glucose stimulus;10.0;0.8933024483968273;0.861892236059334;9.54514264355307;231.89735718708792;5.769740442447999;0.0077613958509799305;0.7103058064080809;[PRKCE, FKBP1B, CFTR, FOXA2]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[IL1RN, ANXA1, HNF1B, ADCYAP1, FKBP1B]
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;5.202362649177086;0.001508456149618737;0.6169684330707209;[CEP55, IER3, PDGFRB, PDGFRA, F2R, TSC2, SIRT1, DCN, FGR, CEACAM1, KIT, TWIST1, PDGFA, CCL5, PDGFD, PDGFC, FYN, PIP5K1B, TGFB2, C3orf58, KLF4, PTK2, SELP, GH1, CD28, PTPN6, TEK]
GO:0030193;regulation of blood coagulation;7.0;0.6696747006330769;0.685756715573739;8.935377071932177;65.68414019264287;5.420364800990877;0.0021983890603594525;0.628117073252615;[PROS1, SERPINE1, PDGFA, THBS1, THBD, PLAU, PDPN, CD36, CD34, LYN, PDGFRA, EDN1, FCER1G, SYK, CAV1, F2R, F11, PRKCD, PLAUR, GP1BA, F3, SELP, CEACAM1, FAP, CD9, SERPING1, PRKCQ, HPSE, TLR4, FOXA2]
GO:0061296;negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;996.6215973313817;9.777073627680469;0.03335602796147551;0.9324289523296623;[HNF1B]
GO:1900212;negative regulation of mesenchymal cell apoptotic process involved in metanephros development;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;461.19708656281085;8.67846133901236;0.015435851436826728;0.8400575416471059;[HNF1B, PAX2]
GO:0023019;signal transduction involved in regulation of gene expression;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;6.781341354126479;7.75488093814194E-4;0.6370391240755715;[FGF5, PDGFRA, EPCAM, HNF4A]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0048557;embryonic digestive tract morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;31.256231937100466;6.832634648514029;0.0010461179541522844;0.639662265535933;[PDGFRA, IHH, HNF1B]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[ABHD12, CHL1, SLITRK6, DRD4, SCN1A, SNCA, TMOD1, NR4A2, CXCL12, FOXA2]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, CTSZ, IHH, PHB2, HOXA11, HHEX, EDNRA, HOXA5, EDN1, HNF1B, PAX2, GREM1, SFRP2, COL4A1, ENG, EPHA2, PAK1, TGFB1, EGF, VDR, PML, PPP1CA, BMP2]
GO:0061017;hepatoblast differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;47.57053087451796;9.083926447120524;0.0015921428576718348;0.7547934328124444;[HHEX, HNF1B]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, CTGF, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, GTF2H1, TAF5]
GO:0055091;phospholipid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.57984905034425;0.0010826797251974863;0.738553198190834;[ABCA1, HNF4A]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, SLC2A2, TNF, HNF4A, SOX4, GHSR, PRKCE, IFNG, IL1B, CFTR, BLK, KCNA5, ITPR3, DPP4, CNR1, CCL5, FKBP1B, FOXA2]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[SLC8A1, CTGF, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, FKBP1B, NOX4]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[HNF1B, SIRT1, PML, PPP1CA, MC3R, LGR4]
GO:0002314;germinal center B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;8.67846133901236;0.005013908926038414;0.8400575416471059;[CDH17]
GO:0002315;marginal zone B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;7.57984905034425;0.005013908926038414;0.7838744581139225;[BCL3, DLL1, CDH17]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, HNF1B, E2F7]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, PML, BCL6, SIPA1]
GO:0001826;inner cell mass cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.390779266560578;7.050676185779127E-4;0.6791048419030481;[HNF1B]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, CALML4, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, LAT]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, KCNH1, KCNH2, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, LRRK2, TNFRSF1B, LCP2, LCP1, DTL, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, RIN2, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, RGL4, CD24, RGL1, CD40, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK3, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EGF, MAPK14, TEK, CYFIP1, EPS8, STMN1, CYP1B1, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, ADM, IFIH1, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, CSPG4, LAT, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0010470;regulation of gastrulation;6.0;0.5860072649471136;0.6161239450637013;7.99439372746765;45.909253739235254;6.139487467954083;0.0015365414070062774;0.6370939872166814;[IL10, IL1RN, HNF1B, KLF4, DUSP6, SFRP2, COL5A1, HNF4A, COL5A2, FOXA2]
GO:0035672;oligopeptide transmembrane transport;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;50.32547990123027;8.16763571524637;0.0016843485223027412;0.7926932703116032;[CDH17]
GO:0065004;protein-DNA complex assembly;6.0;0.6547035408479693;0.6504720830141292;8.32924126836186;63.417908820271286;4.458953633836253;0.0021225403358019965;0.55115140878708;[CCNH, GMNN, DACH1, RUVBL1, HNF1B, PADI4, H1FX, NASP, TCF4, HMGB2, CHAF1B, CHAF1A, BRD2, H2AFX, RAD51C, BDP1, MCM2, HIST1H2BK, TAF9, CENPA, RPA1, GTF2H1, RAD51, CENPH, CENPI, RPA3, CENPK, CENPL, CENPM, CENPN, CENPO]
GO:0033132;negative regulation of glucokinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;694.6793120766872;8.16763571524637;0.023250291404415376;0.8501222226412654;[FOXA2]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, CDH1, MEF2C, ACTN1, COL23A1, CLDN3, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, BCL6, ID1, NOX4, NRP1, COL14A1, ITGB3, LAMC1, ITGB7, ITGA4, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A3, CDH17, YAP1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[JUN, TGFB2, TGFB1, INHBA, FOS, BMP2, HNF4A]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[TNFAIP3, PHB2, PYCARD, CYP1B1, HAVCR2, MEN1, IL10, CHUK, IRAK3, SIRT1, SFRP4, XCL1, SIK1, TWIST1, PKHD1, FLNA, NLRP3, HMOX1, WFS1, KLF4, NFKBIA, NLRP12, ID1, CCDC22, EZH2, FOXA2]
GO:0042663;regulation of endodermal cell fate specification;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;108.59969873383258;8.390779266560578;0.0036347341832379046;0.8041048419030481;[HNF1B, DUSP6]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, STMN1, FBXO5, MAP1B, LLGL2, FIGNL1, PLK2, PLK1, PTK2, KIF11, NUF2, TUBG1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, TUBE1, CENPE, SPC25, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NDC80, KIF18A, FES, CDK1, NAV1, PSRC1, BIRC5, AURKB, WEE1, PRC1, RAN]
GO:0072181;mesonephric duct formation;10.0;1.0;0.9152410118609203;9.628524252492122;118.2658713057263;9.083926447120524;0.003958252280228659;0.8797934328124444;[HNF1B]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, HNF1B, FCER2, MAML3, PSEN2, KCNA5, DLL1, PLN, PERP, S1PR3, ZNF423, TGFB1, JAG1, KRT19, BMP2, SNAI2]
GO:0001678;cellular glucose homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;49.180086311476984;5.514393750639154;0.0016460132296410052;0.6329257181104212;[FOXO1, HK3, LGALS1, SOX4, MEN1, SIRT1, PAX2, NME1, LIN28A, IL1B, NOX4, FOXA3]
GO:2000648;positive regulation of stem cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;63.968874315823136;6.250713103064308;0.002140980655101363;0.6427820713687392;[CX3CR1, SMARCD3, LTBP3, PTPRC, EPCAM]
GO:2000049;positive regulation of cell-cell adhesion mediated by cadherin;6.0;1.0;0.8231203125901445;9.628524252492122;52.08961109106789;7.8311634786251565;0.001743392405611612;0.7236063770733796;[FOXA2]
GO:2000048;negative regulation of cell-cell adhesion mediated by cadherin;7.0;1.0;0.8509193652572005;9.628524252492122;69.05345888857988;8.16763571524637;0.002311157124922504;0.7686126355688037;[EPCAM]
GO:0006182;cGMP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6128.1106202320725;6.558197802812269;0.20510234751766956;0.7678154929528684;[GUCY2C, ADCY9, AQP1]
GO:0060261;positive regulation of transcription initiation from RNA polymerase II promoter;12.0;0.9326813400603323;0.9144609826203107;9.606545345773347;3603.970423346374;6.7325511899570465;0.12062164670659907;0.7924232935401965;[HNF1B, PSMC6, PSMC2]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, SPINT2, PHB2, CYP1B1, EPHB1, SOX7, SOX4, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, GATA3, GATA1, INPP5D, HMOX1, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPB, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0039020;pronephric nephron tubule development;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;58.05347923817328;9.777073627680469;0.001942997705362361;0.875;[HNF1B]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[FGF5, GAB1, INPP5D, PIP5K1B, BMX]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MEF2C, DAPK1, PRKCE, PRKCD, PRKAR1B, PRKCQ, PDGFA, THY1, IQGAP3, LYN, PLK2, PLK1, CDK14, ITK, DUSP6, CIT, RARA, HBEGF, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, TNF, FGF5, EFEMP1, GRAP2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, IGFBP3, VRK1, NRBP1, MELK, BLK, CSF1R, PKMYT1, MAP2K6, BMX, NFKB1, CDK1, LAT, LRRK2, CHUK, LCK, IL3RA, BIRC5, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, IL2RB, PTPN6, CCNH, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, EPHA3, EPHA2, LIF, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, GFRA3, HCK, IL1B, KIT, TLR7, SGK1, TLR4, TLR2, GUCY2C, PAK1, PRKY, KITLG, CAMK4, CAMK1, BUB1B, PDGFRB, PDGFRA, CCNE1, CSF2RB, RASGRP4, SPTA1, CCNB1, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, NCAM1, BUB1, EGF, MAPK14, WEE1, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, RARA, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, BCL3, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPB, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, RGMA, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0072095;regulation of branch elongation involved in ureteric bud branching;8.0;0.8933024483968273;0.8216512241984136;9.56398573135455;152.1578089292043;8.390779266560578;0.005092584931722884;0.8041048419030481;[HNF1B]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, FHL2, HNF4G, BRCA1, NR3C2, HNF4A, YWHAH, CCNE1, RARA, PADI2, YAP1, VDR, NR1H2, DEFA1, NR2F2, NR4A2, NR4A1, NR4A3, RAN]
GO:0000432;positive regulation of transcription from RNA polymerase II promoter by glucose;13.0;1.0;0.9625549647676366;9.628524252492122;6356.890744585131;8.67846133901236;0.21275941239102195;0.9063718812344532;[FOXA2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, IL1B, SATB2, CDX2, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, IRF7, FBP1, AURKB, SNCA, MEIS2]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, CDH17, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0051300;spindle pole body organization;4.0;0.8436909121759173;0.6718454560879586;9.271849308553389;37.692070457630365;7.8311634786251565;0.0012615196775557923;0.6504860644832351;[CALML4]
GO:0010719;negative regulation of epithelial to mesenchymal transition;6.0;0.8259837884571596;0.7361122068187242;9.434368238051164;171.1659509920613;6.481236761676141;0.005728770340349481;0.6545710619905948;[TGFB2, SFRP2, FOXA2]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[HHEX, EPCAM, FRZB, HOXA7, MEF2C, TGFB2, ACE, LIF, HNF1B, RUNX2, PAX2, LIN28A, KIT, HOXB4]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[CAV1, PTK2, CEACAM6, CEACAM5, SNAI2]
GO:0010832;negative regulation of myotube differentiation;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;178.40051173448938;6.943860283624253;0.00597090457771659;0.7301093378270707;[CXCL10, MYOCD, CEACAM5]
GO:0030522;intracellular receptor signaling pathway;5.0;0.6547035408479693;0.617592782284905;7.98629651723503;23.17027026302992;4.6122876537569555;7.75488093814194E-4;0.5261136169673617;[SLA2, ACTN4, CCNE1, PADI2, MAP2K6, VDR, DEFA1, NR2F2, NR4A2, NFKBIA, NR4A1, NR4A3, TGFB1I1, FHL2, HNF4G, TNFAIP3, BRCA1, IFIH1, HNF4A, YWHAH, DDX58, RARA, IRF7, YAP1, NOD2, NR1H2, PML, RAN]
GO:2000971;negative regulation of detection of glucose;5.0;1.0;0.7902410118609202;9.628524252492122;39.91533045260256;9.777073627680469;0.0013359301887834194;0.7902410118609202;[FOXA2]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[F11R, GJC1, CDH5, CDH3, CDH1, EPB41L3, CTNNA1, ECT2, JUP, LSR, ACTN4, GRHL2, GJB2, CLDN3, CDH11, CD9, PKP3, TLN1, CDH17, VCL]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, JUN, HACE1, NR2F2, EZH2, HOXC10, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, CASP8AP2, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, CIITA, FHL2, FASLG, HHEX, BIRC5, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, FOXA3, FOXA2, LOXL2, HMGA1, MXD1, HMGB2, AFF3, LYL1, NUP62, MYOCD, ETV1, ELF3, IRF7, CREB5, TAF9, MAPK14, TAF5, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, SNAI2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPB, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX7, SOX4, EBF1, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, PURA, CDX2, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0006591;ornithine metabolic process;8.0;0.7671156992804218;0.7585578496402109;9.132087366178231;84.28152930688253;7.474488534686424;0.0028208269374494807;0.7572456912631272;[ARG1, HNF4A, ALDH18A1]
GO:0007168;receptor guanylyl cyclase signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;28.111912685638995;7.379178354882098;9.408804185094754E-4;0.728290889492758;[GUCY2C]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[CDKN1A, PLEKHF1, EHMT2, LRRK2, LAMP2, UPP1, SIRT1, SIK1, ATF3, SEH1L, FOXO1, GAS2L1, JUN, EIF2S1, FOXA3]
GO:0061987;negative regulation of transcription from RNA polymerase II promoter by glucose;13.0;0.9326813400603323;0.9288956347978027;9.603206444507832;1118.4464678887912;9.777073627680469;0.03743339674376662;0.9625549647676366;[FOXA2]
GO:0033626;positive regulation of integrin activation by cell surface receptor linked signal transduction;8.0;1.0;0.875;9.628524252492122;166.88419677094737;9.777073627680469;0.005585463879897417;0.875;[CDH17]
GO:0001657;ureteric bud development;8.0;1.0;0.875;9.628524252492122;36.921511297847346;6.139487467954083;0.0012357297559360753;0.6889736746265369;[ROBO2, TGFB1, EPCAM, RARA, SDC1]
GO:0071542;dopaminergic neuron differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;23.8388145050385;6.558197802812269;7.978636679434658E-4;0.6256275524841266;[NR4A2, FOXA2]
GO:2000543;positive regulation of gastrulation;7.0;0.6997970393407541;0.7008178849275776;8.826177779967184;138.04138416360374;7.697632086000634;0.004620120898775711;0.7445766281117727;[FOXA2]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, CEACAM5, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0030111;regulation of Wnt signaling pathway;6.0;0.5902001590945054;0.6182203921373972;7.99439372746765;41.8512380110395;4.069963362931594;0.0014007232725606145;0.5312584282431182;[PPP2R1A, RUVBL2, RUVBL1, SOX7, SOX4, WLS, TLE4, TSC2, HNF1B, SFRP4, DEPDC1B, SFRP2, DAAM2, NAIP, APCDD1, FOXO1, FZD1, EGR1, JUP, FZD5, CAV1, NFKB1, COL1A1, BMP2, SNAI2, CDK14, LRRK2, TNFAIP3, HHEX, AXIN2, AES, GREM1, MDFIC, PFDN5, TLR2, YAP1, LRP1, FRZB, CTHRC1, EGF, TMEM64, MAPK14, SULF1, PPP1CA, SULF2, LGR4]
